Komori
Earnings7840FRANCE BED HOLDINGS CO.,LTD.Information and Communications, Services and Others

Summary of Financial Results for the Fiscal Year Ending March 2026 [Japanese GAAP] (Consolidated)

For the fiscal year ended March 2026, revenue increased 1.9% on growth in the Medical Services business, while operating profit declined 7.7% due to higher personnel and logistics costs and investment expenditures to support business expansion. For the fiscal year ending March 2027, the Company forecasts higher revenue and operating profit, and an annual dividend of ¥42.

Worth reading
48Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
-7.7
Year-on-year change in operating profit (%)
Wording
Conditional
How definitive the wording is.

Results for this period

Full year1 April 2025–31 March 2026ConsolidatedJapanese GAAP
Net Sales61,769¥ millionYear on year +1.9%Progress 97.4%
Operating profit4,335¥ millionYear on year -7.7%Progress 94.2%
Ordinary income4,335¥ millionYear on year -7.4%Progress 92.2%
Net income attributable to owners of the parent2,746¥ millionYear on year -6.8%Progress 89.4%

The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.

Net income per share¥82.04
Operating Margin7
Financial position at period-end
Total assets67,747¥ million
of which net assets 40,162 ¥ millionEquity ratio 59.2%vs. prior year-end +2.0pt

塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.

Cash inflows and outflows
Operating+6,333
Investment-4,323
Financials-2,876
Net change-866

Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.

Cash and cash equivalents at end of period¥12,355 million
Segment revenueMedical Services ¥41,830 million (YoY +3.2%), Interior Health ¥19,380 million (YoY -0.5%)
Segment profitMedical Services ¥3,369 million (YoY -6.2%), Interior Health ¥952 million (YoY -10.7%)
Outlook and shareholder returns
Full-year earnings forecast
Net Sales¥63,400 million (YoY +2.6%)
Operating profit¥4,600 million (YoY +6.1%)
Ordinary income¥4,700 million (YoY +8.3%)
Net income¥3,070 million (YoY +11.7%)
Annual Dividend Forecast¥41 → ¥42(+2.4%)
Payout ratioCurrent fiscal year 49.9 % / Next-year forecast 45.6 %
Factors Behind Changes in Business Performance

Revenue increased due to measures to meet demand for in-home care, expansion of the contractual customer base through customer acquisitions, and increased transactions with hospitals and facilities for older adults. However, operating profit declined as expenditures increased for personnel expenses associated with wage increases, logistics costs, and investments to support business expansion.

Disclosure regarding the going concern assumption

Not applicable.

Change in accounting policy
基準改正に伴う変更 Noそれ以外の変更 No見積りの変更 No修正再表示 No
Changes in the scope of consolidationNew 0 / Excluded 0 / Name of newly added company Not disclosed / Excluded Company Name Not disclosed
Material subsequent eventsNot applicable.
Impairment loss¥0 million
Breakdown of extraordinary income (loss)Extraordinary income Gain on sale of non-current assets ¥0 million / Extraordinary loss Loss on Disposal of Fixed Assets ¥5 million, Business structure improvement costs ¥78 million
Depreciation and amortization¥5,033 million
Availability of Supplementary Financial Results MaterialsYes
Availability of Financial Results BriefingYes (for institutional investors and analysts, scheduled for 4 June 2026)
Issued Shares at Period-End34,747,500
Treasury Shares at Period-End1,374,956
Results for this period
ItemDetails
Fiscal Period ClassificationFull year
Accounting standardsJapanese GAAP
Consolidated / non-consolidatedConsolidated
Period Covered1 April 2025–31 March 2026
Net Sales¥61,769 million (YoY +1.9%)
Operating profit¥4,335 million (YoY -7.7%)
Ordinary income¥4,335 million (YoY -7.4%)
Profit attributable to owners of the parent¥2,746 million (YoY -6.8%)
Net income per share¥82.04
Operating Margin7
Equity ratioEnd of the current fiscal period 59.2 / End of previous period 57.2
Total assets¥67,747 million
Net assets¥40,162 million
Cash flows from operating activities¥6,333 million
Cash flows from investing activities¥-4,323 million
Cash flows from financing activities¥-2,876 million
Cash and cash equivalents at end of period¥12,355 million
Full-year earnings forecastNet Sales ¥63,400 million (YoY +2.6%) / Operating profit ¥4,600 million (YoY +6.1%) / Ordinary income ¥4,700 million (YoY +8.3%) / Net income ¥3,070 million (YoY +11.7%)
Annual Dividend Forecast¥41 → ¥42(+2.4%)
Payout ratioCurrent fiscal year 49.9 % / Next-year forecast 45.6 %
Segment revenueMedical Services ¥41,830 million (YoY +3.2%), Interior Health ¥19,380 million (YoY -0.5%)
Segment profitMedical Services ¥3,369 million (YoY -6.2%), Interior Health ¥952 million (YoY -10.7%)
Depreciation and amortization¥5,033 million
Impairment loss¥0 million
Breakdown of extraordinary income (loss)Extraordinary income Gain on sale of non-current assets ¥0 million / Extraordinary loss Loss on Disposal of Fixed Assets ¥5 million, Business structure improvement costs ¥78 million
Disclosure regarding the going concern assumptionNot applicable.
Change in accounting policyChanges due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No
Changes in the scope of consolidationNew 0 / Excluded 0 / Name of newly added company Not disclosed / Excluded Company Name Not disclosed
Material subsequent eventsNot applicable.
Availability of Supplementary Financial Results MaterialsYes
Availability of Financial Results BriefingYes (for institutional investors and analysts, scheduled for 4 June 2026)
Issued Shares at Period-End34,747,500
Treasury Shares at Period-End1,374,956
Factors Behind Changes in Business PerformanceRevenue increased due to measures to meet demand for in-home care, expansion of the contractual customer base through customer acquisitions, and increased transactions with hospitals and facilities for older adults. However, operating profit declined as expenditures increased for personnel expenses associated with wage increases, logistics costs, and investments to support business expansion.
Items this document does not state (4)
Revision to Earnings ForecastShareholder Return PolicyRegional salesOrders received and order backlog

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Revenue in the Medical Services business grew due to measures to meet demand for in-home care, expansion of its contractual customer base through customer acquisitions, and increased transactions with hospitals and facilities for older adults. On the other hand, the cost burden increased due to higher personnel expenses associated with wage increases, surging logistics costs, and investments to meet expanding demand, resulting in lower profit.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Summary of Financial Results for the Fiscal Year Ending March 2026 [Japanese GAAP] (Consolidated) | FRANCE BED HOLDINGS CO.,LTD. (7840) timely disclosure | Komori